Patents by Inventor Philippe Jean Gervais Ghislain Permanne

Philippe Jean Gervais Ghislain Permanne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VACCINE
    Publication number: 20100184836
    Abstract: This invention relates to novel HIV polypeptide and polynucleotide fusions of Gag, Pol and Nef which are useful in immunogenic compositions and vaccines. The invention relates in particular to a polypeptide which comprises Nef or an immunogenic fragment thereof, and p17 Gag and/or p24 Gag or immunogenic fragments thereof, wherein when both p17 and p24 Gag are present there is at least one HIV antigen or immunogenic fragment between them. The polypeptide may also comprise Pol or RT or an immunogenic fragment thereof.
    Type: Application
    Filed: October 14, 2009
    Publication date: July 22, 2010
    Inventors: Helge ABRECHT, Martine Delchambre, Martine Marchand, Nathalie Louise Mathy, Philippe Jean Gervais Ghislain Permanne, Gerald Hermann Voss
  • Vaccine for prevention and treatment of HIV-infection
    Patent number: 7612173
    Abstract: This invention relates to novel HIV polypeptide and polynucleotide fusions of Gag, Pol and Nef which are useful in immunogenic compositions and vaccines. The invention relates in particular to a polypeptide which comprises Nef or an immunogenic fragment thereof, and p17 Gag and/or p24 Gag or immunogenic fragments thereof, wherein when both p17 and p24 Gag are present there is at least one HIV antigen or immunogenic fragment between them. The polypeptide may also comprise Pol or RT or an immunogenic fragment thereof.
    Type: Grant
    Filed: August 3, 2005
    Date of Patent: November 3, 2009
    Assignee: GlaxoSmithKline Biologicals, s.a.
    Inventors: Helge Abrecht, Martine Delchambre, Martine Marchand, Nathalie Louise Mathy, Philippe Jean Gervais Ghislain Permanne, Gerald Hermann Voss
  • Vaccine for Prevention and Treatment of Hiv-Infection
    Publication number: 20070243203
    Abstract: This invention relates to novel HIV polypeptide and polynucleotide fusions of Gag; Pol and Nef which are useful in immunogenic compositions and vaccines. The invention relates in particular to a polypeptide which comprises Nef or an immunogenic fragment thereof, and p17 Gag and/or p24 Gag or immunogenic fragments thereof, wherein when both p17 and p24 Gag are present there is at least one HIV antigen or immunogenic fragment between them. The polypeptide may also comprise Pol or RT or an immunogenic fragment thereof.
    Type: Application
    Filed: August 3, 2005
    Publication date: October 18, 2007
    Inventors: Helge Abrecht, Martine Delchambre, Martine Marchand, Nathalie Mathy, Philippe Jean Gervais Ghislain Permanne, Gerald Voss
  • Process to concentrate insoluble proteins by vibrating membrane filtration
    Patent number: 6939697
    Abstract: The present invention relates to a process for purifying proteins comprising applying protein extracts to a vibrating membrane fitter equipped with a hydrophilic membrane.
    Type: Grant
    Filed: January 7, 2002
    Date of Patent: September 6, 2005
    Assignee: GlaxoSmithKline Biologicals, s.a.
    Inventors: Benoit Champluvier, Philippe Jean Gervais Ghislain Permanne
  • Process to concentrate insoluble proteins by vibrating membrane filtration
    Publication number: 20040072314
    Abstract: The present invention relates to a process for purifying proteins comprising applying protein extracts to a vibrating membrane fitter equipped with a hydrophilic membrane.
    Type: Application
    Filed: July 9, 2003
    Publication date: April 15, 2004
    Inventors: Benoit Champluvier, Philippe Jean Gervais Ghislain Permanne
  • Prostase protein vaccine comprising derivatised thiol residues and methods for producing said antigen
    Publication number: 20030143240
    Abstract: The present invention relates to chemically modified prostase derivatives, fragments and homologues thereof. Such antigens may be formulated to provide vaccines for the treatment of prostate tumours. Methods for purifying prostase protein and homologues are also provided.
    Type: Application
    Filed: December 20, 2002
    Publication date: July 31, 2003
    Inventors: Teresa Elisa Virginia Cabezon-Silva, Philippe Jean Gervais Ghislain Permanne